CCL14 and hepatocellular carcinoma: Specifically, low CCL14 mRNA expression correlates with worse OS and PFS in HCC patients belonging to stages 1+2 (OS: HR=0.52, P=0.0074; PFS: HR=0.64, P=0.019) or grade 2 (OS: HR=0.52, P=0.012; PFS: HR=0.57, P=0.01).